These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 30350826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.
    Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD.
    Lancet Infect Dis; 2015 Feb; 15(2):225-34. PubMed ID: 25459221
    [Abstract] [Full Text] [Related]

  • 4. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A, Izanloo A, Rastegar M.
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Colistin and polymyxin B in critical care.
    Michalopoulos A, Falagas ME.
    Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical translation of polymyxin-based combination therapy: Facts, challenges and future opportunities.
    Zhang X, Guo F, Shao H, Zheng X.
    J Infect; 2017 Feb; 74(2):118-130. PubMed ID: 27998750
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical Use of Polymyxin B.
    Rigatto MH, Falci DR, Zavascki AP.
    Adv Exp Med Biol; 2019 Feb; 1145():197-218. PubMed ID: 31364080
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Polymyxin B: similarities to and differences from colistin (polymyxin E).
    Kwa A, Kasiakou SK, Tam VH, Falagas ME.
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multidrug-resistant Gram-negative infections: what are the treatment options?
    Giamarellou H, Poulakou G.
    Drugs; 2009 Oct 01; 69(14):1879-901. PubMed ID: 19747006
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME.
    Antimicrob Agents Chemother; 2005 Aug 01; 49(8):3136-46. PubMed ID: 16048915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.